Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease.
Ontology highlight
ABSTRACT: Vaso-occlusive episodes (VOEs) are a major concern in patients with sickle cell disease (SCD). Exposure to systemic corticosteroids has been suspected to increase the occurrence of VOEs in case reports or series. No comparative study has been conducted to investigate this risk, which is still debated. Several clinical trials demonstrated the effectiveness of corticosteroids for the treatment of VOEs, but with increased rates of readmission. The aim of the study was to assess the risk of hospitalization for VOE associated with exposure to systemic corticosteroids in patients with SCD. We used a case-case-time-control design in a nationwide population-based cohort built in the French national health insurance database between 2010 and 2018. The population included all patients with SCD with
SUBMITTER: Walter O
PROVIDER: S-EPMC11290598 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA